Successful vaginal birth after cesarean section is more comfortable than repeat emergency or elective cesarean section. Antenatal examinations are important in selection for trial of labor, while birth management can be difficult when the patients present at emergency condition. But there is an increased chance of vaginal birth with advanced cervical dilation. This study attempts to evaluate factors associated with success of vaginal birth after cesarean section and to compare the maternal and perinatal outcomes between vaginal birth after cesarean section and intrapartum cesarean section in patients who were admitted to hospital during the active or second stage of labor. A retrospective evaluation was made from the results of 127 patients. Cesarean section was performed in 57 patients; 70 attempted trial of labor. The factors associated with success of vaginal birth after cesarean section were investigated. Maternal and neonatal outcomes were compared between the groups. Vaginal birth after cesarean section was successful in 55% of cases. Advanced cervical opening, effacement, gravidity, parity, and prior vaginal delivery were factors associated with successful vaginal birth. The vaginal birth group had more complications (P<0.01), but these were minor. The rate of blood transfusion and prevalence of changes in hemoglobin level were similar in both groups (P>0.05). In this study, cervical opening, effacement, gravidity, parity, and prior vaginal delivery were important factors for successful vaginal birth after cesarean section. The patients’ requests influenced outcome. Trial of labor should take into consideration the patient’s preference, together with the proper setting.
The onset of labor and related labor pain provide a positive contribution to a reduction in neonatal respiratory disorders. Therefore, it can be considered reasonable to perform a cesarean section after the onset of labor or related pain.
This study was approved by Batman Maternity and Child Health Hospital review board (Number: 2020-7) ClinicalTrials.gov Identifier: NCT04183556 All procedures in this study involving human participants were performed in accordance with the 1964 Helsinki Declaration and its later amendments. Conflict of Interest No conflict of interest was declared by the authors.
The aim of this study was to evaluate factors associated with success of induction of labor with dinoprostone vaginal system and assess maternal and fetal outcomes. Material and Method: One hundred and three patients were evaluated retrospectively. Primary outcomes were considered proportion of women achieving vaginal delivery within 24 hours. Secondary outcome measures were assessed as tachysystole, hyper stimulation, oxytocin requirement, cesarean section rate, fetal distress, meconium stained liquor, postpartum hemorrhage, cervical-vaginal tears, fetal death and vaginal birth achieved post hours, and side effects such as hyperprexia, vomiting, and diarrhea. The factors associated with success of dinoprostone use were evaluated comparing between vaginal birth and cesarean section groups, and fetal outcomes were also assessed. Results: The success rate of vaginal birth within 24 hours after induction was 28.2%. Age, parity and cervical opening were associated factors with success of achieving vaginal birth within 24 hours (p<0.01). There were no differences between two groups in terms of maternal and fetal outcomes (p>0.05). Apgar scores also were not different between two groups. The maternal and fetal complications which might be attributed to dinoprostone use were rare. Conclusion: Age, parity and cervical opening were associated factors with success of induction of labor with dinoprostone with rare maternal and fetal complications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.